Dan Hartman

410 total citations
13 papers, 233 citations indexed

About

Dan Hartman is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, Dan Hartman has authored 13 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Public Health, Environmental and Occupational Health, 4 papers in Economics and Econometrics and 3 papers in Infectious Diseases. Recurrent topics in Dan Hartman's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Computational Drug Discovery Methods (2 papers). Dan Hartman is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and Computational Drug Discovery Methods (2 papers). Dan Hartman collaborates with scholars based in United States, United Kingdom and Uganda. Dan Hartman's co-authors include Vincent I. Ahonkhai, Murray Lumpkin, Alasdair Breckenridge, Carl C. Peck, Bernard Vrijens, Jeffrey K Aronson, Terrence F. Blaschke, Sue Fox, Stan Heptinstall and Jane May and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Dan Hartman

11 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Hartman United States	6	60	57	53	33	29	13	233
Cai Liu China	10	19 0.3×	24 0.4×	14 0.3×	30 0.9×	44 1.5×	20	215
Wen Wei Chung Malaysia	8	9 0.1×	43 0.8×	48 0.9×	8 0.2×	68 2.3×	9	329
Zhiying Shen China	11	8 0.1×	86 1.5×	16 0.3×	16 0.5×	39 1.3×	23	356
Pam S. Dellea United States	8	23 0.4×	41 0.7×	74 1.4×	84 2.5×	59 2.0×	11	438
Hassan Egypt	10	14 0.2×	20 0.4×	6 0.1×	40 1.2×	43 1.5×	31	375
Marina Kawaguchi‐Suzuki United States	11	22 0.4×	15 0.3×	11 0.2×	45 1.4×	40 1.4×	24	292
Marie‐Christine Pérault‐Pochat France	9	59 1.0×	39 0.7×	32 0.6×	27 0.8×	39 1.3×	21	394
Yuyan Jin China	13	34 0.6×	15 0.3×	11 0.2×	7 0.2×	40 1.4×	23	314
Hans Mulder Netherlands	7	25 0.4×	19 0.3×	28 0.5×	19 0.6×	85 2.9×	8	337
Shyi-Jang Shin Taiwan	11	6 0.1×	41 0.7×	31 0.6×	28 0.8×	44 1.5×	13	368

Countries citing papers authored by Dan Hartman

Since Specialization

Citations

This map shows the geographic impact of Dan Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Hartman more than expected).

Fields of papers citing papers by Dan Hartman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Hartman. The network helps show where Dan Hartman may publish in the future.

Co-authorship network of co-authors of Dan Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Hartman. A scholar is included among the top collaborators of Dan Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Hartman. Dan Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hartman, Dan, et al.. (2026). Treating Pregnant and Lactating Women: Insights from Clinical Pharmacology. The Annual Review of Pharmacology and Toxicology. 66(1). 191–210.

Brown, Joshua D., Tamra Goodrow, Dan Hartman, et al.. (2022). Application of exposure bracketing to streamline the development of contraceptive products. SHILAP Revista de lepidopterología. 4. 100072–100072.

Hartman, Dan, et al.. (2020). Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID‐19. Clinical and Translational Science. 13(4). 646–648. 4 indexed citations

Yu, Jingjing, Ping Zhao, Susan Hershenson, et al.. (2019). Drug–Drug Interactions of Infectious Disease Treatments in Low‐Income Countries: A Neglected Topic?. Clinical Pharmacology & Therapeutics. 105(6). 1378–1385. 3 indexed citations

Zhao, Ping, Stephen A. Ward, David Hermann, et al.. (2019). Model‐Informed Assessment of Anti‐Infectives for Young Children in Low‐ and Middle‐Income Countries. CPT Pharmacometrics & Systems Pharmacology. 8(4). 201–204. 1 indexed citations

Zineh, Issam & Dan Hartman. (2019). What's Past Is Prologue: Clinical Pharmacology at the Intersection of Science, Policy, and Patients. Clinical Pharmacology & Therapeutics. 107(1). 33–36. 2 indexed citations

Shahin, Mohamed H., Susan M. Abdel‐Rahman, Dan Hartman, et al.. (2019). The Patient‐Centered Future of Clinical Pharmacology. Clinical Pharmacology & Therapeutics. 107(1). 72–75. 4 indexed citations

Breckenridge, Alasdair, Jeffrey K Aronson, Terrence F. Blaschke, et al.. (2017). Poor medication adherence in clinical trials: consequences and solutions. Nature Reviews Drug Discovery. 16(3). 149–150. 53 indexed citations

Ahonkhai, Vincent I., et al.. (2016). Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization. PLoS ONE. 11(11). e0166515–e0166515. 50 indexed citations

10.

Fox, Sue, Jane May, Andrew J. Johnson, et al.. (2012). Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y₁₂antagonist bothin-vitroandex-vivoin human volunteers. Platelets. 24(5). 392–400. 26 indexed citations

11.

Heptinstall, Stan, David Iyú, Ann E. White, et al.. (2008). DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease. Platelets. 19(8). 605–613. 55 indexed citations

12.

Sunitha, Iruvanti, et al.. (1994). Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. Clinical & Experimental Metastasis. 12(2). 143–154. 27 indexed citations

13.

Hartman, Dan, et al.. (1986). Maximizing Social Contact for Secondary Students with Severe Handicaps. Research and Practice for Persons with Severe Disabilities. 11(2). 118–124. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact